A Randomized Trial of Shunting for Idiopathic Normal-Pressure Hydrocephalus

10 major claims checked against the paper's own evidence: all adequately supported.

Recomputed 10 tests: 10 consistent, 0 inconsistent, 10 via agent-written checks.

1 integrity concern flagged (0 high).

14 copyedit issues flagged: mostly consistency, other, clarity.

Checked 43 references: 40 verified — 3 unresolved.

3 data/code links checked; 2 live.

As a published paper, this work is substantively robust for its primary findings (shunt surgery improves gait velocity at 3 months), but an informed reader should weigh the absence of data availability as a limitation for independent verification, and note the incomplete ethics reporting (consent process, regulatory compliance) and the missing randomization details. A correction or erratum addressing these reporting gaps would strengthen the paper's transparency; the missing data availability is the most consequential issue for reproducibility.

1. 1.
   HIGHdata code

   Add a data availability statement specifying where de-identified individual participant data can be accessed (e.g., via a managed-access repository like Vivli or ClinicalTrials.gov results database, or by request to the corresponding author with a data-sharing agreement).

   The absence of any data availability statement is a major reproducibility gap for a publicly funded clinical trial.
2. 2.
   HIGHdata code

   Deposit the de-identified participant-level dataset and analysis code (including custom image-segmentation code) in a public repository with a persistent DOI or accession number, and cite it in the data availability statement.

   Without data and code sharing, independent verification and reuse of the findings are severely limited.
3. 3.
   HIGHethics

   Describe the informed consent process (e.g., written informed consent was obtained from all participants) in the Methods section under 'Participants'.

   A clinical trial must describe how consent was obtained; merely stating count of consenting participants is insufficient.
4. 4.
   HIGHethics

   Add a regulatory compliance statement to the Methods, e.g., 'This study was conducted in accordance with the Declaration of Helsinki and ICH Good Clinical Practice guidelines.'

   International standards for clinical trial reporting require a compliance statement.
5. 5.
   HIGHother

   Verify or correct the following three references that were not found in any registry: 'BDI-II, Beck Depression Inventory: Manual', 'A multiple testing procedure for clinical trials', and 'The combination of probabilities arising from data in discrete distributions'—replace with correct citations if needed.

   References that cannot be located in registries are potential fabrication signals and must be validated.
6. 6.
   HIGHreporting

   Specify the randomization method (e.g., computer-generated random numbers with varying block sizes, stratification factors) in the Methods section under 'Randomization and Blinding'.

   Adequate randomization requires description of the algorithm and allocation concealment; '1:1 ratio' alone is insufficient.
7. 7.
   HIGHreporting

   Report the statistical software used (e.g., SAS version 9.4, R version 4.x) in the Statistical Analysis section.

   Identification of analysis software is standard for reproducibility.
8. 8.
   HIGHreporting

   Provide version numbers or RRIDs for the image segmentation software (spatially localized atlas network tiles, deep-learning brain extraction tool) in the Methods under 'Outcome Measures and Methods'.

   Without software versions, the image analysis cannot be precisely replicated.
9. 9.
   MEDIUMreporting

   Reference the CONSORT 2010 checklist in the Methods or as supplementary material, and include a completed CONSORT flow diagram.

   CONSORT is the standard reporting guideline for RCTs and its use improves completeness.
10. 10.
    MEDIUMcopyedit

    Fix the missing table and figure references throughout the Results: complete sentences like 'Additional details are in the ________' and '() shows the distribution' by inserting the correct supplement/figure/table labels.

    Incomplete references impede reader comprehension and suggest hasty editing.
11. 11.
    MEDIUMcopyedit

    Standardize p-value spacing (use 'P < 0.001' and 'P = 0.003' consistently) and use consistent minus signs (hyphen vs. en-dash) throughout.

    Consistent formatting improves professional appearance and readability.
12. 12.
    MEDIUMcopyedit

    Fix the extraneous hyphen in the Introduction: change '- Untreated, iNPH is associated with...' to 'Untreated, iNPH is associated with...'.

    Grammatical error disrupts reading flow.
13. 13.
    LOWreporting

    Report participant body weight (mean ± SD) in Table 1 to complete the standard demographic variables.

    Weight is a standard demographic variable; its omission is a minor gap for a clinical trial.
14. 14.
    LOWcopyedit

    In Table 3 footnote, clarify that the deceased participant not included in the table is from the Placebo group (to match the text stating 'One death occurred in the Placebo group').

    Consistency between table footnote and main text prevents minor confusion.
15. 15.
    LOWother

    Discuss the substantial imbalance in baseline comorbidities (92.0% Placebo vs. 67.3% Open Shunt for 'Any comorbidities') as a potential chance imbalance and its possible influence on outcomes.

    A reader should be aware of this imbalance despite randomization; it may affect interpretation of secondary outcomes.